CellenGene Achieves US Patent Approval for Breakthrough CAR-T Therapy Targeting Solid Tumors
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
Tag: CellenGene
CellenGene Selected for National New Drug Development Project, Advances CAR-T Therapy for Ovarian Cancer
CellenGene, a biotechnology company specializing in cell gene therapy (CEO: Ahn Jae-hyun), has been selected for the 'New Drug Ecosystem ...
POPULAR POSTS
Speak Easy Labs Korea, the operator of…
by Daehyun Song . 12 Dec 2024 The Ministry of SMEs and Startups (MSS), led by Minister Oh Young-joo, announced its 2025 budget and fund management plan…
by Jinju Jeon . 12 Dec 2024 CLO Virtual Fashion, a Korean digital apparel solution company, has successfully raised 50 billion won (34 million USD) in new…
by Chloe kim . 16 Dec 2024 The 6th edition of COMEUP 2024, a global startup festival organized by the Korea Startup Forum (Chairman Sangwoo Han), concluded…
by KoreaTechDesk Writer . 16 Dec 2024 Korean company Curelation, the operator of KRUSH, a dating community app for Asians, announced on the it has recently received…
by Dae-jung Park . 10 Dec 2024